Patents by Inventor Yuri Hio

Yuri Hio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEART20049410 POLYPEPTIDES AND METHODS OF MAKING THE SAME
    Publication number: 20090311748
    Abstract: Novel full-length cDNAs are provided. cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: July 13, 2009
    Publication date: December 17, 2009
    Applicant: Acceleron Pharma Inc.
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Heart20049410 full-length cDNA and polypeptides
    Patent number: 7560541
    Abstract: Novel full-length cDNAs are provided. cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: July 14, 2009
    Assignee: Acceleron Pharma, Inc.
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • FULL-LENGTH cDNA AND POLYPEPTIDES
    Publication number: 20080032304
    Abstract: cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: June 25, 2007
    Publication date: February 7, 2008
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Full-length cDNA
    Patent number: 7193069
    Abstract: Novel full-length cDNAs are provided. 2443 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: March 20, 2007
    Assignee: Research Association for Biotechnology
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Novel full-length cDNA
    Publication number: 20070015163
    Abstract: Novel full-length cDNAs are provided. 1639 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: June 27, 2005
    Publication date: January 18, 2007
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Novel full-length cDNA
    Publication number: 20060105376
    Abstract: Novel full-length cDNAs are provided. 2443 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: December 5, 2005
    Publication date: May 18, 2006
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Amyloid-? protein aggregation-regulating factors
    Patent number: 7029860
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: April 18, 2006
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita
  • Novel full length cDNA
    Publication number: 20060029945
    Abstract: Novel full-length cDNAs are provided. 1970 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: March 7, 2005
    Publication date: February 9, 2006
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Full-length cDNA
    Patent number: 6979557
    Abstract: Novel full-length cDNAs are provided. 1639 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: December 27, 2005
    Assignee: Research Association for Biotechnology
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Amyloid ? protein agglutination-controlling factor
    Patent number: 6960435
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: November 1, 2005
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita
  • Amyloid-beta protein aggregation-regulating factors
    Publication number: 20050214813
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Application
    Filed: December 17, 2004
    Publication date: September 29, 2005
    Applicant: Fujisawa Pharmaceutical Co. Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita
  • Full-length cDNA
    Patent number: 6943241
    Abstract: Novel full-length cDNAs are provided. 1970 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: September 13, 2005
    Assignee: Research Association for Biotechnology
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Novel full-length cDNA
    Publication number: 20040005560
    Abstract: Novel full-length cDNAs are provided.
    Type: Application
    Filed: March 28, 2002
    Publication date: January 8, 2004
    Applicant: Helix Research Institute
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-Ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Novel full length cDNA
    Publication number: 20030236392
    Abstract: Novel full-length cDNAs are provided.
    Type: Application
    Filed: March 25, 2002
    Publication date: December 25, 2003
    Applicant: Helix Research Institute
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-lchi Yamamoto, Yuuko lsono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro lrie, lchiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Novel full-length cDNA
    Publication number: 20030219741
    Abstract: Novel full-length cDNAs are provided.
    Type: Application
    Filed: March 12, 2002
    Publication date: November 27, 2003
    Applicant: Helix Research Institute
    Inventors: Takao Isogai, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Hiroyuki Sato, Shizuko Ishii, Jun-Ichi Yamamoto, Yuuko Isono, Yuri Hio, Kaoru Otsuka, Keiichi Nagai, Ryotaro Irie, Ichiro Tamechika, Naohiko Seki, Tsutomu Yoshikawa, Motoyuki Otsuka, Kenji Nagahari, Yasuhiko Masuho
  • Neurotrophic factor expression-inducing agent
    Publication number: 20030186332
    Abstract: The culture supernatant of COS cells expressing the PSEC56 gene was found to have a neurite extension effect. The main substance of the activity contained in this culture supernatant was revealed to be NGF. It was shown that PSEC56 can be utilized as a neurotrophic factor expression-inducing agent, and that the NGF induction system can be utilized for drug development against diseases of the nervous system.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 2, 2003
    Inventors: Cristina Mitsumori, Noriyuki Morikawa, Koji Hayashi, Kenji Nagahari, Toshio Ota, Yuri Hio, Tetsuo Nishikawa, Takao Isogai, Masakazu Kawasaki, Kenji Hashimoto, Toshimitsu Kishimoto